Sanofi (SNY) FCF Payout Ratio (2009 - 2025)

Sanofi (SNY) posted FCF Payout Ratio of 0.49 for Q4 2025, up 23.9% sequentially from 0.65 in Q3 2025, and down 3.31% YoY from 0.51 in Q4 2024.

Sanofi (SNY) FCF Payout Ratio (2009 - 2025) Analysis & Trends

Sanofi (SNY) has 9 years of FCF Payout Ratio data on file, last reported at 0.49 in Q4 2025.

  • Quarterly FCF Payout Ratio fell 3.31% year-over-year to 0.49 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.9 (up 8.32% YoY) and the FY2025 annual result came in at 0.01, down 99.34% from the prior year.
  • FCF Payout Ratio climbed to 0.49 in Q4 2025 per SNY's latest filing, from 0.65 in the prior quarter.
  • The five-year high for FCF Payout Ratio was 0.38 in Q4 2022, with the low at 0.87 in Q3 2023.
  • Average FCF Payout Ratio over 5 years is 0.54, with a median of 0.49 recorded in 2024.
  • Year-over-year, FCF Payout Ratio soared 98.11% in 2021 and fell 19.49% in 2024.
  • Sanofi's FCF Payout Ratio stood at 0.4 in 2021, then advanced by 5.32% to 0.38 in 2022, then dropped by 5.42% to 0.4 in 2023, then dropped by 19.49% to 0.48 in 2024, then fell by 3.31% to 0.49 in 2025.
  • Business Quant data shows SNY's FCF Payout Ratio at 0.49 in Q4 2025, 0.65 in Q3 2025, and 0.48 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 0.51
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 2.14
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 0.87
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -6.01
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 0.72
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 0.92
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 0.43
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 1.12
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.49
Dec 31, 2024 -0.48
Dec 31, 2023 -0.40
Dec 31, 2022 -0.38
Dec 31, 2021 -0.40
Dec 31, 2020 -21.26
Dec 31, 2019 -32.85
Dec 31, 2009 -0.81